Left atrial appendage closure during cardiac surgery: Safe but underutilized in California

Joseph Hadaya1, Roland Hernandez2, Yas Sanaiha1

  • 1Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, Calif.

JTCVS Open
|April 17, 2023
PubMed

Insights

Left atrial appendage (LAA) closure in atrial fibrillation (AF) patients undergoing cardiac surgery reduces stroke risk. Despite increased use, significant hospital variations in LAA closure practices persist, indicating a need for standardized care.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Device Technology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia associated with an increased risk of stroke.
  • Left atrial appendage (LAA) closure is an established method to mitigate stroke risk in AF patients.
  • The utilization and outcomes of LAA closure in patients undergoing concomitant cardiac surgery require ongoing evaluation.

Purpose of the Study:

  • To assess trends in LAA closure rates among cardiac surgery patients with AF in California.
  • To determine the association between LAA closure and the incidence of stroke/systemic embolism.
  • To evaluate the safety profile of LAA closure and identify hospital-level variations in its use.

Main Methods:

  • Retrospective analysis of adult patients with AF undergoing coronary artery bypass grafting and/or valve surgery (2016-2019).
  • Utilized California Office of Statewide Health Planning and Development databases.
  • Employed propensity score matching to compare outcomes and intraclass correlation coefficients for hospital variation analysis.

Main Results:

  • LAA closure was performed in 47.7% of 18,434 AF patients, with rates increasing from 44.4% to 51.4% (2016-2019).
  • In matched patients, LAA closure significantly reduced stroke/systemic embolism at discharge (1.6% vs 3.1%) and 1-year readmission (2.9% vs 4.5%).
  • No increased risk of acute kidney injury, pulmonary complications, transfusion, reoperation, or mortality was observed; 18% of variation in LAA use was hospital-attributed.

Conclusions:

  • LAA closure in AF patients undergoing cardiac surgery is safe and effective in reducing short- and midterm stroke/systemic embolism.
  • Despite increasing adoption, significant hospital-level variation in LAA closure practices exists in California.
  • Standardization of LAA closure protocols is recommended to optimize patient care and outcomes.
Abstract